Shandong Weigao Group Medical Polymer Company Limited (stock code 01066) disclosed a repurchase transaction involving 120,000 H shares on 11 February 2026. The highest and lowest repurchase prices per share were HKD 5.32 and HKD 5.30, respectively, with an aggregate cost of approximately HKD 637,200. All repurchased shares were acquired on The Stock Exchange of Hong Kong and were designated as treasury shares.

Following this transaction, the number of issued shares (excluding treasury shares) stood at 4,481,202,324, while the number of treasury shares increased to 41,130,000. These changes represent 0.0027% of the issued share capital prior to the repurchase, based on the opening balance of 4,481,322,324 shares as of 10 February 2026. A repurchase mandate passed on 27 May 2025 authorized up to 451,560,392 shares to be bought back. Since that mandate, 34,481,600 shares have been repurchased, accounting for approximately 7.6361% of the then outstanding share capital.